RIPK1-IN-3
RIPK1-IN-3 (Example 38), a RIPK1 inhibitor, extracted from patent WO2018148626A1, possesses anti-inflammatory proprieties[1].
Product Specifications
CAS Number
2242677-36-5
UNSPSC
12352005
Target
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ripk1-in-3.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC(C2=CC3=NC(N)=NN3C=C2)=CN=C1OC)NC(C4=CC=CC=C4OC(F)(F)F)C
Molecular Formula
C22H19F3N6O3
Molecular Weight
472.42
References & Citations
[1]Guo Junqing, et al. Aminotriazolopyridines as kinase inhibitors. WO/2018/148626A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RIPK1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
